Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LAMB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UBR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SGTA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFSD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBFD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNTB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF622 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RDX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMCO5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIPA1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PXDNL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC149684 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNNM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on